Abstract
In this review we summarize new developments in early diagnosis, establishing surrogate markers, genetics, neuroprotection and cell replacement in Parkinson's disease. Furthermore, we discuss the major problems in the translation of results from preclinical research into successful clinical trials.
Original language | English |
---|---|
Pages (from-to) | VI/33-VI/38 |
Journal | Journal of Neurology, Supplement |
Volume | 251 |
Issue number | 6 |
DOIs | |
Publication status | Published - Sept 2004 |
Externally published | Yes |
Keywords
- Cell replacement
- Diagnosis
- Growth factors
- Neuroprotection
- Parkinson's disease